Nicotinamid-Mononukleotid-Derivate zur Behandlung und Prävention von Polycythämie Vera.

Details

Veröffentlichungs-Nr.

EP4736948

Anmeldetag

17. Dezember 2021

Veröffentlichung

6. Mai 2026

Rechtsraum

EP

IPC

A61P7/06XP093404152 * abstract *

Abstract

The present invention further relates to a compound of Formula (III): <img class="EMIRef" id="6518ceda-e81c-4155-b219-4fe1ba8b0da0-ia01" /> or of Formula (IV): <img class="EMIRef" id="6518ceda-e81c-4155-b219-4fe1ba8b0da0-ia02" /> or a pharmaceutically acceptable salt or solvate thereof; for use in treating a red blood cell disorder, including anemia such as iron deficiency anemia, pernicious anemia, aplastic anemia, autoimmune hemolytic anemia; thalassemia; hemoglobin Sβ0 thalassemia; hemoglobin Sβ+ thalassemia; hemoglobin SC; hemoglobin SD; hemoglobin SE; hemoglobin SS; polycythemia vera and sickle cell disease.

Anmelder

Firma

Nuvamid SA

Land

🇨🇭 Schweiz

Fachgebiete